Residual Disease after Neoadjuvant Therapy for Breast Cancer: Can MRI Help?

被引：8
|
作者：
Hylton, Nola M. [1 ]
机构：
[1] Univ Calif San Francisco, Dept Radiol, 1600 Divisadero St,Room C255, San Francisco, CA 94132 USA
来源：
RADIOLOGY | 2018年 / 289卷 / 02期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1148/radiol.2018181846
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
下载
收藏
页码：335 / 336
页数：2
相关论文
共 50 条
  • [21] Microscopic disease after neoadjuvant therapy in inflammatory breast cancer
    Lodhi, A.
    Mosalpuria, K.
    Krishnamurthy, S.
    Jackson, S.
    Hall, C.
    Andreopoulou, E.
    Singh, B.
    Valero, V.
    Lucci, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy
    Belli, P.
    Costantini, M.
    Malaspina, C.
    Magistrelli, A.
    LaTorre, G.
    Bonomo, L.
    CLINICAL RADIOLOGY, 2006, 61 (11) : 946 - 953
  • [23] Characteristics of residual invasive breast cancer after neoadjuvant therapy in the KATHERINE study
    Mamounas, E. P.
    ANNALS OF ONCOLOGY, 2021, 32 (09) : 1191 - 1192
  • [24] MRI evaluation of residual breast carcinoma after neoadjuvant chemotherapy
    Morvan, A.
    de Korvin, B.
    Bouriel, C.
    Carsin, A.
    Tas, P.
    Bendavid, C.
    Dupre, P. F.
    Kerbrat, P.
    Mesbah, H.
    Poree, P.
    Leveque, J.
    JOURNAL DE RADIOLOGIE, 2010, 91 (06): : 693 - 699
  • [25] Efficacy of breast conserving treatment of minimal residual tumors after neoadjuvant therapy for breast cancer
    Pesotsky, Roman
    Semiglazov, Vladimir
    Krivorotko, Petr
    Tabagua, Tengiz
    Zernov, Konstantin
    Emelyanov, Alexander
    Mortada, Viktoria
    Amirov, Nikolay
    Ulrikh, Daria
    Levchenko, Valerii
    Bondarchuk, Yana
    Enaldieva, Diana
    Bekkeldieva, Nestan
    Zirov, Konsantin
    Yerechshenko, Sergey
    Evseev, Vladislav
    Rychagov, Kirill
    Novikov, Sergey
    Kazantseva, Maria
    Gigolaeva, Larisa
    Zhiltsova, Elena
    Nesterov, Denis
    Ivanova, Olga
    Semiglazova, Tatiana
    CANCER RESEARCH, 2024, 84 (09)
  • [26] Utility of initial MRI for predicting extent of residual disease after neoadjuvant chemotherapy: Analysis of 70 breast cancer patients
    Murata, Y
    Ogawa, Y
    Yoshida, S
    Kubota, K
    Itoh, S
    Fukumoto, M
    Nishioka, A
    Moriki, T
    Maeda, H
    Tanaka, Y
    ONCOLOGY REPORTS, 2004, 12 (06) : 1257 - 1262
  • [27] Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy
    Mueller, Hannah Deborah
    Posch, Florian
    Suppan, Christoph
    Bargfrieder, Ute
    Gumpoldsberger, Melanie
    Hammer, Robert
    Hauser, Hubert
    Dandachi, Nadia
    Prein, Kurt
    Stoeger, Herbert
    Lax, Sigurd
    Balic, Marija
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (13) : 4274 - 4283
  • [28] Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy
    Hannah Deborah Müller
    Florian Posch
    Christoph Suppan
    Ute Bargfrieder
    Melanie Gumpoldsberger
    Robert Hammer
    Hubert Hauser
    Nadia Dandachi
    Kurt Prein
    Herbert Stoeger
    Sigurd Lax
    Marija Balic
    Annals of Surgical Oncology, 2019, 26 : 4274 - 4283
  • [29] MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy
    Chen, Jeon Hor
    Feig, Lyon
    Agrawal, Garima
    Yu, Hon
    Carpenter, Philip M.
    Mehta, Rita S.
    Nalcioglu, Orhan
    Su, Min Ying
    CANCER, 2008, 112 (01) : 17 - 26
  • [30] Accuracy of Posttreatment Imaging for Evaluation of Residual in Breast Disease After Neoadjuvant Endocrine Therapy
    Chi Zhang
    Heidi E. Kosiorek
    Bhavika K. Patel
    Barbara A. Pockaj
    Sarwat B. Ahmad
    Patricia A. Cronin
    Annals of Surgical Oncology, 2022, 29 : 6207 - 6212
12345